Freenome vs ImmunoScape
Freenome vs ImmunoScape, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Freenome is on 59/100 and ImmunoScape on 58/100.
Where each one leads
Freenome
- agent readiness: 46/100 against 39/100
- domain rating: 56/100 against 28/100
- funding raised: $570M against $49.7M
- LinkedIn following: 46,860 against 4,364
ImmunoScape
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Freenome | ImmunoScape |
|---|---|---|
| What it is | Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology. | Developing novel immunotherapies and diagnostics for cancer. |
| Category | Biotechnology, Healthcare, Artificial Intelligence, Biotech | Biotechnology, Cancer, Immunotherapy, Diagnostics |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2014 | 2017 |
| Headquarters | South San Francisco, USA | Singapore, Singapore |
| Status | Active | Active |
Size, funding and growth
| Measure | Freenome | ImmunoScape |
|---|---|---|
| Employees | 402 | Not published |
| Total funding | $570M | $49.7M |
| Latest round | Series D | Series B2 |
| Valuation | $1.1B | $1.1B |
| LinkedIn followers | 46,860 | 4,364 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Freenome | ImmunoScape |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 58/100 |
| Traction | 60/100 | 38/100 |
| Team | Not published | 70/100 |
| Search visibility | 31/100 | 23/100 |
| Quality | 78/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (46/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 56/100 | 28/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Freenome | ImmunoScape |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Google Tag Manager | Google Tag Manager |
| Support stack | HubSpot | Not detected |
What users say
| Measure | Freenome | ImmunoScape |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 6 positive, 0 negative across 6 threads |
“Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments.”r/Quantisnow
Freenome vs ImmunoScape: common questions
Which is better, Freenome or ImmunoScape?
On our 0-100 score Freenome rates higher (59/100 against 58/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Freenome and ImmunoScape compare on the numbers?
Freenome leads on agent readiness (46/100 against 39/100), domain rating (56/100 against 28/100), funding raised ($570M against $49.7M), LinkedIn following (46,860 against 4,364).
What do real users say about Freenome and ImmunoScape?
ImmunoScape: 6 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/Quantisnow.
Read the full Freenome review and pricing or the ImmunoScape review and pricing. You can also browse other Freenome alternatives we track.